The frequency of APP prescription varied between countries and territories, suggesting that a host of clinical and socio-cultural factors played a role in determining APP use in Asia. To resolve the discrepancy between treatment recommendation and clinical practice, regular reviews of prescription patterns are needed.
Nowadays, many countries have been endeavoring to explore and exploit the offshore wind energy in terms of solving the problem of limitations of onshore wind energy. Wind energy is one of potential alternative for generating electricity in Malaysia. The offshore wind speed is better compared to onshore, so there is more potential contribution by offshore wind power in terms of electricity generation. This paper provides a summary of the offshore wind resources of the Kijal, Malaysia by analyzing the QuikSCAT satellite data which is available and can be downloaded from the WindPRO application. Based on these datasets, wind resources are assessed, and economical efficiency is evaluated by means of the expected capacity factor. Research was conducted using WindPRO and WAsP software to assess the potential of wind energy along the South China Sea in Kijal, Terengganu. Seven models of the wind turbines with different rated power; 110kW, 225kW, 275kW, 600kW, 850kW, 1000kW and 1250kW are taken for energy and economic feasibility analyses. The wind turbine with rated power 850 kW was indicated as the best wind turbine for installation in Kijal based on its best capacity factor, 26.8% In economical aspect, Malaysia does not have Feed in Tariff (FiT) rates for offshore wind projects, thus the range of predicted FiT rates, RM 0.30 to RM 2.00 were tested by using Net Present Value (NPV) and Payback Period (PBP) calculation. Finally, the conducive FiT rates for wind projects with secured investment were identified and the rates were in range RM 0.80 to RM 1.38. The overall results suggest that the wind energy has a bright future for use as an alternative source for generating electricity in Kijal, Malaysia.
The wide variation in ACM prescription across Asia suggests that a combination of clinical, social, economic and cultural factors play a role in determining the use of these drugs. Regular reviews of ACM use are desirable to reveal the discrepancy between treatment guidelines and clinical practice.
Sex is one of the independent contributors to psychotropic prescription and side effects in Asian schizophrenia patients. Psychopharmacological treatment guidelines for schizophrenia should consider the sexes separately.
The aim of this study was to predict the wind energy potential over the Langkawi Island, Malaysia. The wind data for year 2009 was collected from Malaysia Meteorology Department (MMD) and then extrapolated to the hub heights of various turbines. Wind turbines with rated powers between 1 kW and 110 kW were chosen for annual energy production calculations and best fitted ones were used for the micrositting analysis. In this study, the turbine with 22 kW rated power with hub height 30 m was selected based on its best value of capacity factor. The wind speed frequency per year is highly peaked in the range 1–6 m/s, this indicate that most of the wind speed at Langkawi Island lies in this range. The ‘WAsP’ and ‘WindPRO’ softwares were used for the wind statistics and energy calculations. Calculated energy production of located 10 turbines with total capacity of 0.22 MW was 111.1 MWh. Suitable sites were selected according to the created wind power and energy maps. The future cost of maintenance and the status of area either its reserved or conserved by the government were the factors that be considered for selection of site area.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.